Liu T, Yuan S, Zhang L, Zhang D
Molecules. 2025; 30(5).
PMID: 40076220
PMC: 11901814.
DOI: 10.3390/molecules30050995.
Li T, Chen X, Tong W
NPJ Digit Med. 2024; 7(1):310.
PMID: 39501092
PMC: 11538515.
DOI: 10.1038/s41746-024-01317-z.
Chen S, Yu M, Yao Y, Li Y, He A, Zhou Z
Environ Health (Wash). 2024; 2(6):350-372.
PMID: 39473465
PMC: 11503987.
DOI: 10.1021/envhealth.3c00184.
Aljarallah N, Dutta A, Sait A
Int J Mol Sci. 2024; 25(12).
PMID: 38928128
PMC: 11203850.
DOI: 10.3390/ijms25126422.
Zhang S, Zhao D, Cui Q
ACS Omega. 2024; 9(16):17839-17847.
PMID: 38680329
PMC: 11044234.
DOI: 10.1021/acsomega.3c07682.
Cell Painting-based bioactivity prediction boosts high-throughput screening hit-rates and compound diversity.
Fredin Haslum J, Lardeau C, Karlsson J, Turkki R, Leuchowius K, Smith K
Nat Commun. 2024; 15(1):3470.
PMID: 38658534
PMC: 11043326.
DOI: 10.1038/s41467-024-47171-1.
Integration of machine learning models with microsatellite markers: New avenue in world grapevine germplasm characterization.
Abbasi Holasou H, Panahi B, Shahi A, Nami Y
Biochem Biophys Rep. 2024; 38:101678.
PMID: 38495412
PMC: 10940787.
DOI: 10.1016/j.bbrep.2024.101678.
The Future of Material Scientists in an Age of Artificial Intelligence.
Maqsood A, Chen C, Jacobsson T
Adv Sci (Weinh). 2024; 11(19):e2401401.
PMID: 38477440
PMC: 11109614.
DOI: 10.1002/advs.202401401.
Cytokines inhibitory mechanism of L. (Plum) peptides as potential immunomodulators against systemic lupus erythematosus: an in-silico screening.
Gupta A, Jamal T, Rajbhar P, Gaur A, Chauhan S, Parthasarathi R
In Silico Pharmacol. 2024; 12(1):12.
PMID: 38370860
PMC: 10866836.
DOI: 10.1007/s40203-023-00188-8.
Difficulty in chirality recognition for Transformer architectures learning chemical structures from string representations.
Yoshikai Y, Mizuno T, Nemoto S, Kusuhara H
Nat Commun. 2024; 15(1):1197.
PMID: 38365821
PMC: 10873378.
DOI: 10.1038/s41467-024-45102-8.
Toxicogenomics Approaches to Address Toxicity and Carcinogenicity in the Liver.
Pandiri A, Auerbach S, Stevens J, Blomme E
Toxicol Pathol. 2024; 51(7-8):470-481.
PMID: 38288963
PMC: 11014763.
DOI: 10.1177/01926233241227942.
Artificial intelligence (AI)-it's the end of the tox as we know it (and I feel fine).
Kleinstreuer N, Hartung T
Arch Toxicol. 2024; 98(3):735-754.
PMID: 38244040
PMC: 10861653.
DOI: 10.1007/s00204-023-03666-2.
Redesigning plant specialized metabolism with supervised machine learning using publicly available reactome data.
Lim P, Julca I, Mutwil M
Comput Struct Biotechnol J. 2023; 21:1639-1650.
PMID: 36874159
PMC: 9976193.
DOI: 10.1016/j.csbj.2023.01.013.
Identification of and Mechanistic Insights into SARS-CoV-2 Main Protease Non-Covalent Inhibitors: An In-Silico Study.
Shen J, Du W, Xia Y, Zhang Z, Yu Z, Fu Y
Int J Mol Sci. 2023; 24(4).
PMID: 36835648
PMC: 9959744.
DOI: 10.3390/ijms24044237.
Use of clinical chemistry health outcomes and PFAS chain length to predict 28-day rodent oral toxicity.
Bellia G, Bilott R, Sun N, Thompson D, Vasiliou V
Toxicol Mech Methods. 2022; 33(5):378-387.
PMID: 36446747
PMC: 10625160.
DOI: 10.1080/15376516.2022.2150591.
Quantum-based machine learning and AI models to generate force field parameters for drug-like small molecules.
Mudedla S, Braka A, Wu S
Front Mol Biosci. 2022; 9:1002535.
PMID: 36304919
PMC: 9592901.
DOI: 10.3389/fmolb.2022.1002535.
Machine Learning Models for Identification and Prediction of Toxic Organic Compounds Using Transcriptomic Profiles.
Choi T, An H, Kim C
Life (Basel). 2022; 12(9).
PMID: 36143479
PMC: 9503646.
DOI: 10.3390/life12091443.
A p53 transcriptional signature in primary and metastatic cancers derived using machine learning.
Keshavarz-Rahaghi F, Pleasance E, Kolisnik T, Jones S
Front Genet. 2022; 13:987238.
PMID: 36134028
PMC: 9483853.
DOI: 10.3389/fgene.2022.987238.
On modeling and utilizing chemical compound information with deep learning technologies: A task-oriented approach.
Lim S, Lee S, Piao Y, Choi M, Bang D, Gu J
Comput Struct Biotechnol J. 2022; 20:4288-4304.
PMID: 36051875
PMC: 9399946.
DOI: 10.1016/j.csbj.2022.07.049.
Towards a comprehensive assessment of QSP models: what would it take?.
Androulakis I
J Pharmacokinet Pharmacodyn. 2022; 51(5):521-531.
PMID: 35962928
PMC: 9922790.
DOI: 10.1007/s10928-022-09820-0.